Primary Care Reports – April 1, 2005
April 1, 2005
View Issues
-
After Vioxx: The Issue of Safety in Prescribing COX-2 Inhibitors
After the voluntary withdrawal of Vioxx from the market in September 2004 following reports of increased cardiovascular events associated with the drug, there was a call from some quarters for a similar action for all selective COX-2 inhibitors (coxibs). This article reviews the current clinical knowledge regarding the coxibs and their cardiovascular effects. Recommendations for prescribing anti-inflammatory drugs in common clinical situations are provided. -
Pharmacology Watch: Preparing for the Possibility of a Bird Flu Pandemic
The possibility of a bird flu pandemic has health officials worldwide in a high state of alert. -
Clinical Briefs in Primary Care Supplement